Christie Hospital NHS Foundation Trust-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2022

  1. Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours (Nature Communications, (2020), 11, 1, (737), 10.1038/s41467-019-14052-x)

    Nature Communications

2021

  1. EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers

    Gut, Vol. 70, Núm. 9, pp. 1632-1641

2020

  1. Divergent mutational processes distinguish hypoxic and normoxic tumours

    Nature Communications, Vol. 11, Núm. 1